NCCN antiemesis guidelines emphasize 'delayed' emesis, new 5-HT3 inhibitors, and NK-1 blockers.

Source :: The journal of supportive oncology [J Support Oncol] 2004 Jul-Aug; Vol. 2 (4), pp. 366.
Publication Year :: 2004

Subjects :: Antineoplastic Agents adverse effects
Humans
Nausea chemically induced
Nausea prevention & control
Practice Guidelines as Topic
Practice Patterns, Physicians'
United States
Vomiting chemically induced
Vomiting prevention & control
Antiemetics therapeutic use
Nausea drug therapy
Neurokinin-1 Receptor Antagonists
Serotonin 5-HT3 Receptor Antagonists
Vomiting drug therapy

Tools